Table 2 Patient’s demographics and clinical characteristics

Gender

Females, N = 17 (38.6%)

Males, N = 27 (61.4%)

Age

Range 8.10–47.17 years

Mean = 17.17 years

Grade

High grade, N = 34 (77.3%)

Missing data, N = 10 (22.7%)

Histological subtypes

Conventional, N = 34 (89.5%)

Variant, N = 4 (10.5%)

Missed data, N = 6

Metastasis at diagnosis

Yes, N = 11 (25%)

No, N = 33 (75%)

Neoadjuvant chemotherapy

MAP, N = 30 (68.2%)

Cisplatin & Doxorubicin, N = 11 (25.0%)

Other, N = 3 (6.80%)

Tumor location

Arm, N = 3 (6.8%)

Femur, N = 22 (50%)

Tibia, N = 15 (34.1%)

Other, N = 4 (9.1%)

Response to chemotherapy

Good, N = 16 (36.4%)

Poor, N = 28 (63.6%)